- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Granulocyte-colony stimulating factor (G-CSF)
Total 808 results
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell Lymphoma (DLBCL) | Elderly Patients (>65 Years)Italy
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedLeukemia | Stem Cell TransplantationUnited States
-
Northwestern UniversityTerminatedMyasthenia GravisUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
M.D. Anderson Cancer CenterCompleted
-
University of Campinas, BrazilCompletedViral ConjunctivitisBrazil
-
Memorial Sloan Kettering Cancer CenterRecruitingNewly Diagnosed Ewing SarcomaUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
National Cancer Institute (NCI)TerminatedPost-transplant Lymphoproliferative Disorder | Recurrent Childhood Large Cell Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Recurrent Childhood Small Noncleaved Cell Lymphoma | Recurrent/Refractory Childhood Hodgkin Lymphoma | AIDS-related Peripheral/Systemic Lymphoma | AIDS-related...United States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI)Completed
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedMetastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell CarcinomaUnited States
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedOvarian Cancer | Teratoma | Childhood Germ Cell TumorUnited States
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaTerminatedSarcoma | Kidney Cancer | Brain and Central Nervous System Tumors | Retinoblastoma | Liver CancerUnited States
-
Nationwide Children's HospitalWithdrawnCrohn's Disease
-
M.D. Anderson Cancer CenterBiogenCompletedLymphomaUnited States
-
ORA, Inc.CompletedAllergic ConjunctivitisUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMedulloblastoma | Anaplastic MedulloblastomaUnited States, Canada, Puerto Rico, Australia, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEpendymoma | Anaplastic Ependymoma | Clear Cell Ependymoma | Brain Ependymoma | Cellular Ependymoma | Papillary EpendymomaUnited States, Canada, Australia, New Zealand
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
Australasian Gastro-Intestinal Trials GroupThe University of New South Wales; Walter and Eliza Hall Institute of Medical...Recruiting
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Northwestern UniversityTerminated
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Cancer | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder Cancer | Localized Transitional Cell Cancer... and other conditions
-
National Cancer Institute (NCI)RecruitingPrimary Mediastinal Large B-Cell LymphomaUnited States, Canada, Australia, Puerto Rico
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingRefractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8United States
-
Northwestern UniversityTerminatedScleroderma, SystemicUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma... and other conditionsUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Canadian Cancer Trials GroupRoche Pharma AG; Janssen, LP; Karyopharm Therapeutics IncRecruiting
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLymphoma | Thrombocytopenia | Brain and Central Nervous System Tumors | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI); Iovance BiotherapeuticsActive, not recruitingMalignant Solid Neoplasm | Metastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Platinum-Resistant Ovarian Carcinoma | Metastatic Pancreatic Ductal Adenocarcinoma | Metastatic Ovarian Carcinoma and other conditionsUnited States
-
Masonic Cancer Center, University of MinnesotaNot yet recruitingAcquired Pure Red Cell Aplasia | Paroxysmal Nocturnal Hemoglobinuria | Severe Aplastic Anemia | Acquired Amegakaryocytic Thrombocytopenia
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedSevere Aplastic AnemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedFanconi AnemiaUnited States
-
Northwestern UniversityTerminated
-
Northwestern UniversityTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico
-
Asan Medical CenterJanssen Korea, Ltd., KoreaCompletedLymphoma, B-Cell | Lymphoma, Large-Cell, DiffuseKorea, Republic of
-
University of BolognaUnknownNon-Hodgkin's Lymphoma | Acute Lymphoblastic LeukemiaItaly
-
M.D. Anderson Cancer CenterCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Adult Malignant Mesenchymoma | Alveolar Childhood Rhabdomyosarcoma | Embryonal Childhood Rhabdomyosarcoma | Embryonal-botryoid Childhood Rhabdomyosarcoma | Previously... and other conditionsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Myeloid Leukemia With BCR-ABL1United States